Vertex Pharmaceuticals Incorporated · Cambridge, MA United States ·(NASDAQ (GS): VRTX)

Vertex Pharmaceuticals represents the convergence of drug discovery technologies. The biotechnology company uses an integrated, multidisciplinary approach -- employing biophysics, computer-based modeling, and functional genomics -- to speed up the discovery and development of new drugs. It is focused primarily on the development of its lead candidate, telaprevir, an investigational treatment for hepatitis C. The company has a couple of other hepatitis C drugs in development, as well as possible treatments for cystic fibrosis, inflammatory disease, and cancer. Vertex, which was formed in 1989, has facilities in California and Massachusetts, and in the UK. To read the full description, subscribe now.